The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 110.50
Ask: 112.50
Change: 0.00 (0.00%)
Spread: 2.00 (1.81%)
Open: 115.50
High: 119.50
Low: 110.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Trading Update

2 May 2019 07:00

RNS Number : 8667X
McBride PLC
02 May 2019
 

2 May 2019

 

McBride plc

 

Directorate Change and Trading Update

 

Directorate Change

 

McBride plc (the "Company") announces that Rik De Vos, CEO, has informed the Board of his decision to leave the Company. A search will commence immediately and Rik has advised the Board that he will remain in position while his successor is being recruited.

 

John Coleman, Chairman, said:

"Rik has brought a strong vision and laid the foundations of the Company's transformation through the "Manufacturing our Future" strategy. I would like to take this opportunity to thank him on behalf of the Board and colleagues for his contribution. I would also like to thank Rik for agreeing to assist the Board to ensure a smooth handover of his responsibilities. The Board wishes him every success in his future endeavours."

 

Rik De Vos, CEO, said:

"In recent years, we have achieved much in a challenging trading environment. We have developed a clear strategy in "Manufacturing our Future" and delivered clear benefits from implementing the "Repair, Prepare, Grow" phases. However, I now consider that the Group requires different leadership to deliver the next phase of its growth ambitions. I'm confident that I will be leaving McBride well positioned to realise these ambitions."

 

An announcement will be made regarding Rik's successor and his departure date in due course.

 

Trading update

 

Following a weak third quarter trading period, the Group now anticipates that its full year earnings will be modestly lower than current market expectations, primarily as a result of weaker than expected sales activity in Germany, France and Italy.

 

The Group expects to provide a trading update for the 12 months ending 30 June 2019 in early July.

 

 

For further information please contact:

McBride plc

John Coleman, Chairman

Chris Smith, CFO

0161 203 7570

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

 Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

 

Addendum - CEO Remuneration disclosures

 

Salary and Benefits 

 

Rik will receive payments during his notice period of six months in accordance with his contractual entitlement namely base salary, payments in lieu of pension contributions and benefits. His benefits consist of a company car, private healthcare, disability insurance and life cover. Full details of Rik's contractual entitlements are included in the Remuneration report 2018.

 

Incentives

 

Entitlements to any bonus payment for the current financial year, unvested LTIP entitlements and unvested shares under the deferred bonus plan lapse with this resignation. Full details of unvested awards are included in the Remuneration report 2018.

 

Full details of any relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments to be made in the notice period are in accordance with the Directors' Remuneration Policy which was approved by shareholders on 24 October 2017.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUUCAUPBUAP
Date   Source Headline
29th Dec 20205:19 pmRNSTransaction in Own Shares
21st Dec 20207:18 amRNSTransaction in Own Shares
17th Dec 20205:13 pmRNSTransaction in Own Shares
16th Dec 20204:59 pmRNSTransaction in Own Shares
15th Dec 20205:07 pmRNSTransaction in Own Shares
14th Dec 20205:19 pmRNSTransaction in Own Shares
11th Dec 20205:42 pmRNSTransaction in Own Shares
11th Dec 20209:30 amRNSAppointment of new Chief Financial Officer
10th Dec 20205:10 pmRNSTransaction in Own Shares
9th Dec 20204:49 pmRNSTransaction in Own Shares
4th Dec 20207:00 amRNSTrading Update
3rd Dec 20205:17 pmRNSTransaction in Own Shares
2nd Dec 20205:08 pmRNSTransaction in Own Shares
1st Dec 20205:00 pmRNSTransaction in Own Shares
30th Nov 20206:09 pmRNSIssue of B Shares as part of B Share Scheme
30th Nov 20205:01 pmRNSTransaction in Own Shares
27th Nov 20204:50 pmRNSTransaction in Own Shares
26th Nov 20205:16 pmRNSTransaction in Own Shares
25th Nov 20205:06 pmRNSTransaction in Own Shares
24th Nov 20205:12 pmRNSTransaction in Own Shares
23rd Nov 20205:04 pmRNSResult of AGM
23rd Nov 20204:52 pmRNSTransaction in Own Shares
23rd Nov 20207:00 amRNSAGM Trading Update
20th Nov 20205:08 pmRNSTransaction in Own Shares
20th Nov 20207:00 amRNSTransaction in Own Shares
18th Nov 20205:14 pmRNSTransaction in Own Shares
17th Nov 20205:21 pmRNSTransaction in Own Shares
16th Nov 20205:06 pmRNSTransaction in Own Shares
13th Nov 20204:50 pmRNSTransaction in Own Shares
12th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20204:52 pmRNSTransaction in Own Shares
10th Nov 20205:12 pmRNSTransaction in Own Shares
9th Nov 20205:11 pmRNSTransaction in Own Shares
6th Nov 20204:51 pmRNSTransaction in Own Shares
5th Nov 20205:42 pmRNSTransaction in Own Shares
4th Nov 20205:04 pmRNSTransaction in own shares
3rd Nov 20205:27 pmRNSTransaction in own shares
3rd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSShare buyback of up to 10% of issued share capital
30th Oct 20207:00 amRNSTotal Voting Rights
21st Oct 20209:11 amRNSDirectorate Change
21st Oct 20208:44 amRNSHolding(s) in Company
20th Oct 20207:00 amRNSAnnual Report 2020 and Annual General Meeting 2020
19th Oct 20201:25 pmRNSDirector/PDMR Shareholding
16th Oct 20207:00 amRNSHolding(s) in Company
17th Sep 20201:34 pmRNSDirector/PDMR Shareholding
16th Sep 202010:33 amRNSDirector/PDMR Shareholding
14th Sep 20203:16 pmRNSDirector/PDMR Shareholding
11th Sep 20205:00 pmRNSDirector/PDMR Shareholding
11th Sep 20205:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.